The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab
Papadopoulou, Erofili, Nicolatou-Galitis, Ourania, Papassotiriou, Ioannis, Linardou, Helena, Karagianni, Aikaterini, Tsixlakis, Konstantinos, Tarampikou, Anthi, Michalakakou, Kelly, Vardas, Emmanouil,Language:
english
Journal:
Supportive Care in Cancer
DOI:
10.1007/s00520-019-04793-2
Date:
April, 2019
File:
PDF, 233 KB
english, 2019